Ocular involvement in toxic epidermal necrolysis

References

• Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 1956; 68: 355–361
   PubMed Web of Science ®Google Scholar
• Bergoend H, Loefler A, Amar R, Maleville J. Réactions cutanées survenues au cours de la prophylaxie de masse de la méningite cérébro-spinale par un sulfamide long-retard. Ann Dermatol Syphilol 1968; 95: 481–490
   Google Scholar
• Roujeau J-C, Chosidow O, Saiag P, Guillaume J-C. Toxic epidermal necrolysis (Lyell's syndrome). J Am Acad Dermatol 1990; 23: 1039–1058
   PubMed Web of Science ®Google Scholar
• Goldstein S M, Wintrob B W, Ellas P M. Toxic epidermal necrolysis: unmuddying the waters. Arch Dermatol 1987; 123: 1153–1155
   PubMedGoogle Scholar
• Chan H L, Stern R S, Arndt K A, Langlois J, Jick S S, Jick H, Walker A M. The incidence of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol 1990; 126: 43–47
   PubMed Web of Science ®Google Scholar
• Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp J F. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 1991; 127: 839–842
   PubMedGoogle Scholar
• Roujeau J-C, Guillaume J-C, Fabre J P, Penso D, Fléchet M L, Girre J P. Toxic epidermal necrolysis (Lyell's syndrome): incidence and drug etiology in France, 1981–1985. Arch Dermatol 1990; 126: 37–42
   PubMed Web of Science ®Google Scholar
• Strom B L, Carson J L, Halpern A C, Schinnar R, Snyder E S, Shaw M, et al. A population-based study of Stevens-Johnson syndrome. Incidence and antecedent drug exposure. Arch Dermatol 1991; 127: 831–838
   PubMedGoogle Scholar
• Guillaume J-C, Roujeau J-C, Revuz J, Penso D, Touraine R. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol 1987; 123: 1166–1170
   PubMedGoogle Scholar
• Correia O, Chosidow O, Saiag P, Bastuji-Garin S, Revuz J, Roujeau J-C. Evolving pattern of drug-induced toxic epidermal necrolysis. Dermatology (Basel) 1993; 186: 32–37
   PubMed Web of Science ®Google Scholar
• Merot Y, Saurat J H. Clues to pathogenesis of toxic epidermal necrolysis. Int J Dermatol 1985; 24: 165–168
   PubMed Web of Science ®Google Scholar
• Roujeau J-C, Huynh T N, Bracq C, Guillaume J-C, Revuz J, Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 1987; 123: 1171–1173
   PubMed Web of Science ®Google Scholar
• Mondino B J, Brown S I, Biglan A W. HLA antigens in Stevens-Johnson syndrome with ocular involvement. Arch Ophthalmol 1982; 100: 1453–1454
   PubMedGoogle Scholar
• Delgado L, Correia O, Resende C, Fleming-Torrinha J A. Toxic epidermal necrolysis: an equivalent to the acute-graftversus-host-disease? (abstract). Arq Med 1990; 4: 185
   Google Scholar
• Burge S M, Dawber R P. Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus. J Am Acad Dermatol 1985; 13: 665–666
   PubMed Web of Science ®Google Scholar
• Roujeau J-C, Phlippoteau C, Koso M, Wechsler J, Binaghi M, Revuz J, Touraine R. Séquelles oculaires et syndrome sec au décours du syndrome de Lyell. Ann Dermatol Venereol 1985; 112: 883–888
   PubMed Web of Science ®Google Scholar
• Revuz J, Penso D, Roujeau J-C, Guillaume J-C, Payne C R, Wechsler J, Touraine R. Toxic epidermal necrolysis. Clinical findings and prognostic factors in 87 patients. Arch Dermatol 1987; 123: 1160–1165
   PubMed Web of Science ®Google Scholar
• Wachtel T L. Major burns. What to do at scene and en route to the hospital. Postgrad Med 1989; 85: 178–196
   Google Scholar
• Mondino B J. Bullous diseases of the skin and mucous membranes. Duane's Clinical Ophthalmology, W Tasman, E A Jaeger. JB Lippincott, Philadelphia 1991; 4: 1–19, Ch 12
   Google Scholar
• Westley E D, Wechsler H L. Toxic epidermal necrolysis: Granulocytic leukopenia as a prognostic indicator. Arch Dermatol 1984; 120: 721–726
   PubMedGoogle Scholar
• Tegelberg-Stassen M JAM, van Vloten W A, Faille H B. Management of nonstaphylococcal TEN: Follow up study of 16 case histories. Dermatologica 1990; 180: 124–129
   PubMedGoogle Scholar
• Binaghi M, Koso M, Saiag P h, Roujeau J C, Coscas G. Atteinte oculaire au cours du syndrome de Lyell. Incidence, évolution, prognostic. Ophtalmologie 1988; 2: 121–122
   PubMedGoogle Scholar
• Amon R B, Dimond R L. Toxic epidermal necrolysis. Rapid differentiation between staphylococcal and drug induced disease. Arch Dermatol 1975; 111: 1433–1437
   Google Scholar
• Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol 1979; 100: 69–86
   PubMed Web of Science ®Google Scholar
• Roujeau J-C, Philippoteau C, Koso M, Wechsler J, Andre C, Binaghi M, Revuz J, Touraine R. Sjögren-like syndome after drug-induced toxic epidermal necrolysis. Lancet 1985; 1: 609–611
   PubMed Web of Science ®Google Scholar
• Schiodt M, Thorn J. Criteria for the salivary component of Sjögren's syndrome. A review. Clin Exp Rheumatol 1989; 7: 119–122
   PubMed Web of Science ®Google Scholar
• Chan S H, Tan T. HLA and allopurinol drug eruption. Dermatologica 1989; 179: 32–33
   PubMedGoogle Scholar
• Prendiville J S, Hebert A A, Greenwald M J, Esterly N B. Management of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. J Pediatr 1989; 115: 881–887
   PubMed Web of Science ®Google Scholar
• Honig P J. Corticosteroids for erythema multiforme?. Pediatr Dermatol 1989; 6: 233–235
   Web of Science ®Google Scholar
• Saurat J H, Salomon D. Corticosteroids for erythema multiforme?. Pediatr Dermatol 1989; 6: 235–236
   Web of Science ®Google Scholar
• Renfro L, Grant-Kels J M, Daman L A. Drug-induced toxic epidermal necrolysis treated with cyclosporine. Int J Dermatol 1989; 28: 441–444
   PubMed Web of Science ®Google Scholar
• Roujeau J-C, Moritz S, Guillaume J-C, et al. Lymphopenia and abnormal balance of T-lymphocyte subpopulations in toxic epidermal necrolysis. Arch Dermatol Res 1985; 277: 24–27
   PubMed Web of Science ®Google Scholar
• Villada G, Roujeau J-C, Clérici T, Bourgault I, Revuz J. Immunopathology of toxic epidermal necrolysis: keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Arch Dermatol 1992; 128: 50–53
   PubMed Web of Science ®Google Scholar
• Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y. T-cell subsets in drug-induced toxic epidermal necrolysis: possible pathogenic mechanisms induced by CD8-positive T-cells. Arch Dermatol 1991; 127: 851–855
   PubMedGoogle Scholar
• Correia O, Delgado L, Ramos J P, Resende C, Fleming-Torrinha J A. Cutaneous T-cell recruitment in TEN. Further evidence of CD8+ lymphocyte involvement. Arch Dermatol, (in press)
   Google Scholar
• Tseng S CG. Topical tretinoin treatment for severe dry-eye disorders. J Am Acad Dermatol 1986; 15: 860–866
   PubMed Web of Science ®Google Scholar